• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Parkinson's Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global parkinson's disease treatment market grew at a CAGR of around 6% during 2014-2019. Parkinson’s disease refers to a progressive neurological disorder caused by the degeneration of motor neurons in the brain. It is characterized by rigidity, tremors, difficulty in walking, motor impairment, depression and dementia. Some of the common treatment options for this disorder include medications, supportive therapies and surgical procedures, such as deep brain stimulation. Medications include carbidopa-levodopa medicines, dopamine agonists, monoamine oxidase B (MAO B) inhibitors, catechol O-methyltransferase (COMT) inhibitors and anticholinergics. These treatment methods are highly effective in managing the symptoms of Parkinson’s disease and providing comfort to the patient in case of a seizure.

The increasing prevalence of Parkinson’s disease, and the rising geriatric population across the globe, which is more susceptible to neurodegenerative ailments, represent as the key factors driving the growth of the market. Furthermore, the increasing awareness among the masses regarding the available treatment alternatives is also stimulating the market growth. In line with this, COMT inhibitors are gaining immense traction among healthcare providers and patients. They are administered along with co-therapeutic agents and carbidopa-levodopa therapy for maximum efficiency. Additionally, various innovations in the disease treatment methods, such as the development of neurostimulation tools, gene therapy and neural transplantation procedures, are acting as other growth-inducing factors. These procedures aid in prolonged action of unremitting dopaminergic stimulation medicines and facilitate slowing down the disease progression, which, in turn, is creating a positive outlook for the market. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market further. Looking forward, IMARC Group expects the global parkinson’s disease treatment market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global parkinson's disease treatment market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, drug class, route of administration and distribution channel.

Breakup by Drug Class:

  • Carbidopa/Levodopa
  • Dopamine Receptor Agonists
  • MAO Inhibitors
  • COMT Inhibitors
  • Anticholinergics
  • Others
     

Breakup by Route of Administration:

  • Oral
  • Transdermal
  • Subcutaneous
  • Intestinal Infusion
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Acadia Pharmaceuticals Inc., Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG), F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, H. Lundbeck A/S , Merck & Co. Inc., Mylan N.V., Novartis AG, Orion Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries and Wockhardt Ltd.

Key Questions Answered in This Report:

  • How has the global parkinson’s disease treatment market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global parkinson’s disease treatment market?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global parkinson’s disease treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Parkinson’s Disease Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Carbidopa/Levodopa
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Dopamine Receptor Agonists
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    MAO Inhibitors
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    COMT Inhibitors
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Anticholinergics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Route of Administration
    7.1    Oral
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Transdermal
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Subcutaneous
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Intestinal Infusion
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retailer Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AbbVie Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Acadia Pharmaceuticals Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio 
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Boehringer Ingelheim International GmbH (C. H. Boehringer Sohn AG & Co. KG)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
        14.3.4    F. Hoffmann-La Roche AG
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 SWOT Analysis
        14.3.5    GlaxoSmithKline Plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    H. Lundbeck A/S 
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Merck & Co. Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio 
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Mylan N.V.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Novartis AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio 
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Orion Corporation
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Sun Pharmaceutical Industries Ltd.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio 
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Teva Pharmaceutical Industries
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio 
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Wockhardt Ltd. 
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio 
           14.3.13.3 Financial

List of Figures

Figure 1: Global: Parkinson’s Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Parkinson’s Disease Treatment Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Parkinson’s Disease Treatment Market: Breakup by Drug Class (in %), 2019
Figure 4: Global: Parkinson’s Disease Treatment Market: Breakup by Route of Administration (in %), 2019
Figure 5: Global: Parkinson’s Disease Treatment Market: Breakup by Distribution Channel (in %), 2019
Figure 6: Global: Parkinson’s Disease Treatment Market: Breakup by Region (in %), 2019
Figure 7: Global: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Parkinson’s Disease Treatment (Carbidopa/Levodopa) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Parkinson’s Disease Treatment (Dopamine Receptor Agonists) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Parkinson’s Disease Treatment (MAO Inhibitors) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Parkinson’s Disease Treatment (COMT Inhibitors) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Parkinson’s Disease Treatment (Anticholinergics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Parkinson’s Disease Treatment (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Parkinson’s Disease Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Parkinson’s Disease Treatment (Oral) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Parkinson’s Disease Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Parkinson’s Disease Treatment (Transdermal) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Parkinson’s Disease Treatment (Transdermal) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Parkinson’s Disease Treatment (Subcutaneous) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Parkinson’s Disease Treatment (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Parkinson’s Disease Treatment (Intestinal Infusion) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Parkinson’s Disease Treatment (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Global: Parkinson’s Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: Global: Parkinson’s Disease Treatment (Retailer Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: Global: Parkinson’s Disease Treatment (Retailer Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: Global: Parkinson’s Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: North America: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: North America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: United States: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: United States: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: Canada: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: Canada: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Asia Pacific: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Asia Pacific: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: China: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: China: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Japan: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Japan: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: India: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: India: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: South Korea: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: South Korea: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Australia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Australia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: Indonesia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: Indonesia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: Europe: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: Europe: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: Germany: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: Germany: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: France: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: France: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: United Kingdom: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: United Kingdom: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Italy: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Italy: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Spain: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Spain: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Russia: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Russia: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Latin America: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: Latin America: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Brazil: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Brazil: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Mexico: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 79: Mexico: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 80: Others: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 81: Others: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 82: Middle East and Africa: Parkinson’s Disease Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 83: Middle East and Africa: Parkinson’s Disease Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 84: Global: Parkinson’s Disease Treatment Industry: SWOT Analysis
Figure 85: Global: Parkinson’s Disease Treatment Industry: Value Chain Analysis
Figure 86: Global: Parkinson’s Disease Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Parkinson’s Disease Treatment Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2020-2025
Table 3: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
Table 4: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
Table 5: Global: Parkinson’s Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Parkinson’s Disease Treatment Market Structure
Table 7: Global: Parkinson’s Disease Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links